PATENT CLAIM ANALYSIS

Application Number: 16035309
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "489000"]

Abstract:
The invention relates to a hemostatic composition in powder form comprising collagen of the fibrillar type comprising a content of fibrous collagen and/or fibrillar collagen of at least 70% by weight relative to the total weight of the collagen, and at least one monosaccharide, and optionally, at least one compound selected from coagulation factors and glycosaminoglycans. The invention further relates to a method for preparing such composition, and to a unit comprising such composition and a spraying device.

Claim (Index 24):
The composition of  claim 1 , wherein said composition comprises a collagen content ranging from 80% to 90% by weight relative to the total weight of the composition.

Metadata:
- Claim Count in Document: 67.0
- Percentile: 95.0
- Lexical Diversity: 1.80851
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15048647', '15465408', '14007798', '14131012', '13411324']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7385777427805862
- 35 USC 102 Novelty (BERT): 0.5685670720282632
- Combined Prediction Score: 0.7215766757053539
- Mean Citation Score: 341.2108100000001
- Max Citation Score: 425.4407
- Similarity Product: 423.55209422572256

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test